A patient with a history of type 2 diabetes presents with numbness and tingling in the feet, blurred vision, and elevated blood glucose levels. Which interdisciplinary action should the nurse prioritize to prevent further diabetic complications?

C) Collaborate with a dietitian to develop a personalized meal plan

A) Refer the patient to an ophthalmologist for an eye examination

B) Schedule an appointment with a podiatrist for a comprehensive foot evaluation

C) Collaborate with a dietitian to develop a personalized meal plan

D) Initiate patient education on the importance of regular physical activity

A patient with type 2 diabetes presents with numbness and tingling in the feet, blurred vision, and an elevated fasting blood glucose level. The nurse notes diminished sensation in the feet and a BMI of 31 kg/m². Which intervention should the nurse prioritize to address the patient's risk factors for diabetic complications?

B) Educate the patient on the importance of regular foot care and daily inspections.

A) Recommend an immediate increase in Lisinopril dosage to control blood pressure.

B) Educate the patient on the importance of regular foot care and daily inspections.

C) Suggest starting insulin therapy to improve glycemic control.

D) Advise the patient to undergo immediate surgical intervention for diabetic retinopathy.

A patient with type 2 diabetes presents with an HbA1c level of 8.5%, elevated serum creatinine, reduced GFR, and early-stage diabetic retinopathy. Which nursing intervention is most appropriate to prioritize in the care plan to address the patient's condition?

C) Provide instruction on the use of a glucometer for regular blood glucose monitoring.

A) Educate the patient on the importance of adhering to a low-sodium diet to manage blood pressure.

B) Initiate a referral to a nephrologist for further evaluation of kidney function.

C) Provide instruction on the use of a glucometer for regular blood glucose monitoring.

D) Discuss the potential benefits and side effects of GLP-1 receptor agonists with the patient.

A 55-year-old patient with type 2 diabetes has been identified with an HbA1c level of 8.5%, early-stage diabetic retinopathy, and stage 3 chronic kidney disease. Which nursing intervention is the most appropriate to prioritize in this case to prevent further complications?

C) Emphasize the need for strict adherence to the prescribed glycemic control regimen.

A) Educate the patient on the importance of routine eye examinations.

B) Discuss with the patient the benefits of a low-protein diet to manage kidney function.

C) Emphasize the need for strict adherence to the prescribed glycemic control regimen.

D) Encourage the patient to increase fluid intake to support kidney health.

A patient with type 2 diabetes and chronic kidney disease is on a revised treatment plan that includes lifestyle modifications and medication adjustments. Given the recent lab results and the nephrologist's recommendation, which nursing intervention is most important to prioritize in managing this patient's care?

D) Reinforcing adherence to the newly prescribed ACE inhibitor to provide renal protection.

A) Encouraging the patient to increase protein intake to support weight loss efforts.

B) Educating the patient on the importance of monitoring and maintaining stable blood glucose levels to prevent further kidney damage.

C) Advising the patient to limit fluid intake to prevent fluid overload due to decreased kidney function.

D) Reinforcing adherence to the newly prescribed ACE inhibitor to provide renal protection.

A patient with type 2 diabetes and chronic kidney disease has recently been started on an ACE inhibitor. The nurse is preparing to educate the patient about the new medication. Which of the following statements should the nurse include in the teaching plan?

B) 'You should monitor your blood pressure regularly, as this medication can cause it to drop.'

A) 'It's important to drink plenty of fluids to help your kidneys while taking this medication.'

B) 'You should monitor your blood pressure regularly, as this medication can cause it to drop.'

C) 'Expect a slight increase in your blood sugar levels initially, but this will stabilize over time.'

D) 'If you experience a dry cough, you should stop taking the medication immediately.'

A patient who has recently started on an ACE inhibitor presents with intermittent dizziness upon standing and a slight increase in serum potassium level. What is the nurse's priority action to address the patient's symptoms and laboratory findings?

A) Instruct the patient to reduce dietary sodium intake to manage hypertension.

C) Recommend the patient to increase fluid intake to dilute serum potassium levels.

D) Suggest the patient discontinue the ACE inhibitor until dizziness subsides.

A patient on an ACE inhibitor presents with improved blood pressure control but reports dizziness upon standing. The nurse notes a drop in systolic blood pressure when changing positions, and the patient's serum potassium is elevated. What is the most appropriate initial nursing intervention to address the patient's dizziness?

C) Advise the patient to rise slowly from sitting or lying positions

A) Increase fluid intake to prevent dehydration

B) Encourage the patient to consume high-potassium foods

C) Advise the patient to rise slowly from sitting or lying positions

D) Discontinue the ACE inhibitor immediately

During a follow-up visit, a patient with diabetes and hypertension is found to have a slight increase in serum creatinine levels while on ACE inhibitor therapy. Which nursing intervention should be prioritized to address the potential renal implications and support the patient's overall health management?

B) Collaborate with the healthcare provider to evaluate the current medication regimen and consider adjusting the ACE inhibitor dosage.

A) Encourage the patient to increase fluid intake to flush out the kidneys.

B) Collaborate with the healthcare provider to evaluate the current medication regimen and consider adjusting the ACE inhibitor dosage.

C) Advise the patient to reduce physical activity to minimize fatigue and renal workload.

D) Reassure the patient that mild increases in creatinine are normal and do not require immediate action.

A patient with a history of hypertension and diabetes is experiencing episodes of dizziness and mild swelling in the lower extremities. The nurse notes an increased serum creatinine level from 1.2 mg/dL to 1.4 mg/dL. Which nursing intervention is most appropriate to address the potential renal impairment in this patient?

C) Suggest the patient reduce their protein intake to decrease renal workload.

A) Encourage the patient to increase their fluid intake to maintain hydration.

B) Recommend a low-sodium diet to help manage blood pressure and reduce edema.

C) Suggest the patient reduce their protein intake to decrease renal workload.

D) Advise the patient to discontinue the ACE inhibitor to prevent further renal damage.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In type 1 diabetes, autoimmune destruction of pancreatic beta cells leads to insufficient insulin production, resulting in elevated blood glucose levels due to impaired cellular glucose uptake.

• Secondary mechanism: In type 2 diabetes, insulin resistance occurs, where cells fail to respond effectively to insulin, coupled with eventual beta-cell dysfunction, causing progressive hyperglycemia.

• Key complication: Persistent hyperglycemia from either type can cause microvascular damage, leading to complications such as neuropathy, retinopathy, and nephropathy, significantly impacting patient quality of life and increasing healthcare needs.

Patient Profile

Demographics:

52 years old, male, office worker

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and numbness in feet

• Key symptoms: Blurred vision, frequent urination, occasional dizziness, tingling in extremities

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 180 mg/dL (fasting)

Section 1

During the initial assessment, the nurse observes that the patient displays signs of peripheral neuropathy, as evidenced by the numbness and tingling sensations in the feet. The patient's blurred vision and frequent urination suggest potential diabetic retinopathy and early signs of nephropathy, necessitating further investigation. The patient's elevated fasting blood glucose level of 180 mg/dL indicates poor glycemic control, which is concerning given his history of type 2 diabetes. Additionally, the blood pressure reading of 145/90 mmHg, despite being on Lisinopril, highlights suboptimal hypertension management, which could further exacerbate diabetes-related complications.

The nurse conducts a comprehensive foot examination, noting decreased sensation to monofilament testing and diminished vibratory sense, which raises concerns about the risk for foot ulcers. The patient's body mass index (BMI) is calculated at 31 kg/m², classifying him as obese, which is a contributing factor to insulin resistance. The clinical picture points toward the need for a multidisciplinary approach to manage the patient's diabetes and associated risk factors effectively. This includes addressing lifestyle modifications, optimizing medication regimens, and considering referrals to specialists such as an endocrinologist and a dietitian.

Based on these findings, the healthcare team plans to conduct further diagnostic tests, including an HbA1c test to evaluate long-term glycemic control and a comprehensive metabolic panel to assess kidney function. Additionally, an eye examination is recommended to check for diabetic retinopathy. The patient's symptoms and assessment findings indicate a progression of diabetic complications, emphasizing the importance of timely interventions to prevent further deterioration and improve overall health outcomes. As the case unfolds, the results of these diagnostic tests will guide the next steps in the patient's management plan, requiring continued clinical reasoning and collaboration among healthcare providers.

Section 2

Following the initial assessment and subsequent diagnostic evaluations, the results reveal a HbA1c level of 8.5%, confirming inadequate long-term glycemic control in the patient. The comprehensive metabolic panel shows an elevated serum creatinine of 1.4 mg/dL and a reduced glomerular filtration rate (GFR) of 58 mL/min/1.73 m², suggesting the onset of stage 3 chronic kidney disease, likely secondary to diabetic nephropathy. Furthermore, the eye examination conducted by an ophthalmologist indicates early-stage diabetic retinopathy, characterized by microaneurysms and some retinal hemorrhaging, necessitating close monitoring and potential intervention to prevent vision loss.

These findings indicate a progression in diabetes-related complications, emphasizing the critical need for a more aggressive and multidisciplinary management approach. The healthcare team decides to intensify the patient's glycemic control regimen by adjusting his oral hypoglycemic medications and considering the introduction of a GLP-1 receptor agonist to address both hyperglycemia and weight management. Additionally, a consultation with a nephrologist is arranged to manage the early signs of nephropathy. The patient is also referred to a dietitian to tailor a meal plan that promotes weight reduction and better blood glucose control.

The patient expresses motivation to improve his health outcomes, providing an opportunity for the nurse to engage in patient education focusing on lifestyle modifications, including dietary changes and the importance of regular exercise. The nurse also reinforces the significance of blood glucose monitoring and adherence to medication regimens. These interventions aim to mitigate the progression of complications and enhance the patient's quality of life. As the care plan evolves, ongoing monitoring and adjustments will be essential to address the patient's complex needs and prevent further deterioration of his diabetic condition.

Section 3

Several weeks into the revised treatment plan, the patient returns for a follow-up visit. During the initial assessment, the nurse notes that the patient has lost 5 pounds since the last visit, reflecting positive engagement with the dietary and exercise recommendations. His blood pressure is measured at 135/85 mmHg, slightly improved but suggesting a need for continued monitoring. The patient reports increased adherence to his blood glucose monitoring and medication regimen, which has resulted in more stable readings, typically ranging between 110-140 mg/dL before meals.

New diagnostic results indicate a modest decrease in HbA1c to 7.9%, showing an initial positive response to the intensified glycemic control strategy. However, the comprehensive metabolic panel reveals a slight increase in serum creatinine to 1.5 mg/dL, with a further reduction in GFR to 55 mL/min/1.73 m², indicating a progression in kidney dysfunction. The nephrologist recommends the initiation of an ACE inhibitor to provide renal protection and to address any underlying hypertension, which could further exacerbate nephropathy.

Despite these mixed results, the patient remains motivated and expresses a strong commitment to continue improving his health. The clinical team, recognizing the importance of multidisciplinary support, emphasizes the need for consistent follow-ups with the dietitian and nephrologist. This collaborative approach aims to fine-tune the management plan and address any emerging challenges, ensuring a comprehensive strategy to slow the progression of complications and maintain the patient's quality of life. The nurse discusses the importance of ongoing lifestyle modifications and adherence to the newly prescribed ACE inhibitor, reinforcing the patient's role in managing his condition actively.

Section 4

Several weeks after the initiation of the ACE inhibitor, the patient returns for a scheduled follow-up. During the initial assessment, the nurse finds that the patient's blood pressure has improved further, now measuring at 128/82 mmHg, indicating a positive response to the antihypertensive treatment. However, the patient reports experiencing intermittent episodes of dizziness, particularly upon standing, which suggests the possibility of orthostatic hypotension as a side effect of the new medication. The nurse conducts an orthostatic blood pressure measurement, revealing a drop of 15 mmHg in systolic pressure when the patient moves from a sitting to a standing position, confirming the suspicion.

A new set of diagnostic results provides additional insights into the patient's current health status. The patient's serum potassium level has increased slightly to 5.3 mEq/L, likely related to the initiation of the ACE inhibitor, which can cause hyperkalemia. The nurse discusses this finding with the clinical team, who decide to adjust the patient's diet to reduce potassium intake and closely monitor his electrolyte levels. Meanwhile, the patient's HbA1c has further decreased to 7.6%, reflecting continued improvement in glycemic control.

The nurse educates the patient about managing and recognizing symptoms of orthostatic hypotension, such as advising him to rise slowly from sitting or lying positions. The patient is also informed about dietary adjustments to manage potassium levels without compromising his nutritional needs. This comprehensive approach underscores the importance of patient education and adherence to both medication and lifestyle modifications. The clinical team schedules more frequent follow-ups to ensure that these new challenges are effectively addressed, aiming to prevent any further complications and sustain the patient's progress.

Section 5

A few weeks later, the patient returns for another scheduled follow-up visit. During this visit, the nurse conducts a thorough initial assessment and notes that the patient continues to experience episodes of dizziness, although they have become less frequent with the implementation of slow-position changes. The patient's blood pressure remains stable at 130/80 mmHg while sitting, but still shows a slight drop upon standing, indicating ongoing but improving orthostatic hypotension management. The patient reports increased fatigue and mild swelling in the lower extremities, prompting the nurse to perform a detailed review of the patient's current medications and adherence to lifestyle recommendations.

New diagnostic results reveal that the patient's serum potassium has returned to a normal range at 4.9 mEq/L, suggesting that dietary modifications have been effective. However, the patient's kidney function tests, specifically serum creatinine, have shown a slight increase to 1.4 mg/dL from the previous 1.2 mg/dL. This raises a concern for potential renal impairment, possibly exacerbated by the ACE inhibitor therapy. The nurse discusses these findings with the clinical team, who consider adjusting the medication dosage and initiating a renal-protective dietary plan to prevent further deterioration of kidney function.

The clinical team emphasizes the importance of monitoring renal function closely and maintaining open communication with the patient regarding any new symptoms or changes in health status. The patient is advised to monitor daily weight and report any changes in swelling or urine output promptly. As the patient's journey continues, the focus shifts to balancing effective hypertension management with the protection of renal health, highlighting the necessity of coordinated care and vigilant monitoring in the management of chronic conditions like diabetes. This approach aims to mitigate risks and foster long-term stability in the patient's health.